Healthcare Pharmaceutical Biotech

Medical Care Technologies Inc. (OTCID:MDCE) Subsidiaries Infinite Auctions and Real Game Used Complete first transaction with Fanatics / Topps

September 22, 2026 9:17 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced that its subsidiaries have completed the first executed transaction under the previously disclosed Fanatics / Topps arrangement: Infinite Auctions has sold game-worn sports memorabilia to Topps, and Real Game Used has photo-match authenticated the items supplied in that sale. The update follows the Company's September 14 announcement that Infinite Auctions and Real Game Used had...

Read more

Jaguar Health Receives Fee Waivers from FDA

September 22, 2026 9:05 AM

Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) family company Napo Pharmaceuticals (Napo) today announced that the U.S. Food and Drug Administration (FDA) has granted Napo's request for a waiver of the fee associated with the Prescription Drug User Fee Act (PDUFA) for Mytesi® (crofelemer delayed-release tablets) for the 2027 fiscal year. Mytesi is an FDA-approved prescription drug for the symptomatic relief of noninfectious diarrhea in adult...

Read more

Revecore Launches Legal Appeals Service to Pursue the Complex Denials Hospitals Struggle to Overturn

September 22, 2026 9:03 AM

Revecore, a leading provider of complex revenue cycle management solutions for hospital systems nationwide, today announced the launch of its Legal Appeals service, a new capability designed to recover the most complex, escalated denials that fall outside the reach of existing denial management tools. Revecore's Legal Appeals service is staffed by in-house attorneys, leveraging Revecore's ReClaim™ platform, who apply a layered approach of...

Read more

MCS Accelerates Catheter Manufacturing with QuickShip PTFE Glass Mandrels

September 22, 2026 9:00 AM

As material sciences continue to advance, bringing innovations to the medical device industry, Medical Components Specialists (MCS) is at the forefront of the latest materials as they shape the way products are manufactured. For decades, PTFE was an excellent material known for its durability, biocompatibility, and chemical resistance. Now, PTFE glass-filled mandrels are rivaling traditional stainless steel. Unlike stainless steel, PTFE glass...

Read more

TailorMed CEO Srulik Dvorsky to Lead Panel Session at NASP InSPire 2026

September 22, 2026 9:00 AM

TailorMed, a medication solution platform, announced that Srulik Dvorsky, its co-founder and chief executive officer, will moderate a panel session discussing the implementation of AI-enabled automated patient service solutions during the National Association of Specialty Pharmacy (NASP) InSPire 2026 conference. The event will take place September 22-25, 2026, at the Gaylord National Resort & Convention Center in National Harbor, Maryland....

Read more

Vogenx Appoints Ken Toombs to Board of Directors

September 22, 2026 9:00 AM

Vogenx, Inc. (Nasdaq:VOGX), a clinical-stage developer of novel therapeutics for the treatment of serious metabolic and gastrointestinal diseases, today announced the appointment of Ken Toombs to its Board of Directors, effective September 21, 2026. Mr. Toombs will serve as an independent director and as Chair of the Audit Committee. Mr. Toombs is a thirty-year veteran of the global professional services industry, most recently serving as Chief...

Read more

Physician Cites Stemtech as "Cornerstone" Behind His Focus on STEM Cell Medicine

September 22, 2026 8:30 AM

Stemtech Corporation (OTC PINK:STEK) today announced that Dr. Zahoorudin, a physician and board-certified diplomate of the American Academy of Stem Cell Physicians, based in Pakistan, has identified Stemtech's stem cell nutrition science as the cornerstone of his decision to build his medical practice and research around stem cell utilization. Dr. Zahoorudin, who began studying Stem Cells & Regenerative Medicine in 2008 - years before stem cell...

Read more

Valion Bio Regains Compliance with NASDAQ Minimum Bid Price Listing Rule

September 22, 2026 8:00 AM

Valion Bio, Inc. (Nasdaq:VBIO) ("Valion" or the "Company) announced today that it has received formal written notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum closing bid price of $1.00 per share. Valion satisfied the requirement by...

Read more

Transforming Lung Cancer Care & Early Detection in Tanzania

September 22, 2026 7:29 AM

Originally published on Devex Lung cancer remains the leading cause of cancer death worldwide, yet in resource-limited settings, patients face severe barriers to early diagnosis-while TB is regularly identified and treated, signs and indications of lung cancer are often overlooked. In this interview, Dr. Nestory Masalu, Head of Oncology for the Catholic University of Health and Allied Sciences/Bugando Medical Center, explains how his team is...

Read more

Avel eCare Celebrates Telehealth Awareness Week With Theme "Expert Care. Human Connection"

September 22, 2026 7:22 AM

Technology has changed. Healthcare has changed. And the ways clinicians connect with patients and one another have changed. But for Avel eCare, one thing has remained constant: the people at the heart of care. During Telehealth Awareness Week 2026, Avel eCare is celebrating that commitment with this year's theme: Expert Care. Human Connection. For more than 30 years, Avel eCare has used technology to connect healthcare teams with clinical...

Read more

Zomedica Announces Strategic Partnership with Veterinary Study Groups (VMG) to Deliver Advanced Veterinary Technologies to Independent Practices

September 22, 2026 6:00 AM

Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the "Company"), an animal health company offering innovative point-of-care diagnostic and therapeutic products for equine and companion animals, today announced a new strategic partnership with Veterinary Management Groups (VMG), one of the veterinary industry's most respected organizations, supporting more than 2,000 members across the United States. This agreement, effective September 1, 2026 through...

Read more

Enyrgy Appoints Dr. Derrick Holman as Medical Director

September 22, 2026 6:00 AM

Enyrgy Inc. has named Derrick Holman, M.D., as Medical Director, a critical role in supporting the efficacy of the Company's Vitamin D wellness platform. Dr. Holman will oversee the clinical questions that govern the Enyrgy Vitamin D Primal Light Platform itself: who it is suitable for, how it responds to what a user tells it, and where it defers to a person's own physician. He will also lead Enyrgy's direct outreach to the wellness community...

Read more

AlzeCure Pharma to Present at Swiss Nordic Bio 2026 in Zurich

September 22, 2026 4:20 AM

AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer's disease and pain, today announced that the company will participate and present at Swiss Nordic Bio 2026 in Zurich on October 1, a partnering and investor conference connecting Nordic, Swiss and Austrian companies in biotech, medtech and pharma with global investors and industry representatives. At the...

Read more

GFS Chemicals Partners With Bioz to Turn Data Into Deeper Product Engagement

September 22, 2026 4:00 AM

Bioz, Inc., the leading scientific validation platform that brings publication-backed evidence directly into the product experience, announced its partnership with GFS Chemicals. Through the implementation of Bioz Badges across its product webpages, GFS Chemicals is giving researchers immediate access to peer-reviewed scientific evidence while creating a more informative digital buying experience. Each Bioz Badge dynamically displays citations,...

Read more

SynAct Pharma to Participate in Investor and Partnering Conferences

September 22, 2026 1:30 AM

SynAct Pharma AB (publ) ("SynAct") (STO:SYNACT), a clinical-stage biotechnology company focused on treating inflammation through a novel therapeutic approach known as "pro-resolution", today announced its attendance and presentations at multiple upcoming conferences in September and October 2026. BioStock Investing in Life Science 2026, September 22, Stockholm, Sweden Format: Company presentation Presenting: Jeppe Øvlesen, Chief Executive...

Read more

Independent Provider Network Orchestration Buyers Prioritize Cross-EHR Coordination and Accountability, Black Book Survey Finds

September 21, 2026 3:20 PM

Independent provider networks are prioritizing orchestration technology that coordinates work across different electronic health record systems and makes responsibility for care actions visible and verifiable, according to Black Book Research's Q3 2026 Independent Provider Network Orchestration Competitive Report Card. Among surveyed provider-network clients, 92% identify cross-EHR coordination as a high or critical priority, 84% require the...

Read more

Gastro Center of Maryland Welcomes New Physicians Amid Continued Growth Across 11 Locations

September 21, 2026 12:00 PM

Gastro Center of Maryland (GCM), one of the region's largest gastroenterology practices, has added several new physicians to its clinical team, continuing a period of steady growth that has expanded patient access across 11 Maryland locations. The incoming providers join a team of more than 30 board-certified gastroenterologists, hepatologists, nurse practitioners, physician assistants and registered dietitians serving patients throughout...

Read more

Moderna Announces Late-Breaking Data to be Presented at ESMO Congress 2026

September 21, 2026 10:12 AM

Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on intismeran autogene, an investigational mRNA-based individualized neoantigen therapy, have been accepted for presentation at the European Society for Medical Oncology (ESMO) Congress 2026, which will be held October 23-27 in Madrid, Spain. The presentation details are as follows: Presidential Symposium: LBA1- INTerpath-001: Phase 3 study of the mRNA-based individualized...

Read more

Northern Illinois Recovery Center Expands Teen Outpatient Care with PHP and IOP Programs

September 21, 2026 10:00 AM

Northern Illinois Recovery Center (NIRC) in Crystal Lake, IL, is addressing critical gaps in adolescent addiction and mental health care through specialized Partial Hospitalization (PHP) and Intensive Outpatient (IOP) programs designed to provide teens with intensive clinical support while allowing them to remain connected to their families, schools, and everyday lives. The Programs were developed in response to a growing need for adolescent...

Read more

Medical Care Technologies Inc. (OTCID:MDCE) Presents StrainScan Pro for the First Time in Restaurant Service

September 21, 2026 9:17 AM

Medical Care Technologies Inc. (OTCID:MDCE) today announced that StrainScan Pro is being presented for the first time in restaurant service - advancing last week's announcement that the Company was preparing that demonstration. The platform is live at https://strainscanpro.com. On September 18, MDCE said it was preparing its first StrainScan Pro demonstration built specifically for restaurant service. That was the planning step. This release is...

Read more